ONE-WAYDated event · through FY2025

New Sanford, U.S. Biopharmaceutical API Manufacturing Plant

A large-scale capital investment plan to build a new biopharmaceutical API manufacturing plant in Sanford, North Carolina. Construction is scheduled to begin in the second half of 2024, with completion planned for 2027.

Companies1How many companies write about this.

Threads1One company can carry more than one thread here.

PeriodFY2024-H1 →Last written FY2025

Directionhelps1 helps · 0 hurts · 0 flat